6 unknown. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
Follow Sarcoma, Soft Tissue: new trials by email Literature Review of Sarcoma, Soft Tissue trials Research Report on Sarcoma, Soft Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma Recombinant anti-PD-1 humanized monoclonal antibody injection - Sarcoma, Soft Tissue | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 30 | 2022-01-25 | 2022-01-14 |
| A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma 609A, doxorubicin hydrochloride - Sarcoma, Soft Tissue | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 70 | 2021-12-30 | 2021-11-30 |
| The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma Sintilimab, Doxorubicin Hydrochloride, Ifosfamide - Sarcoma, Soft Tissue | Phase 2 | Unknown | Fudan University | 45 | 2020-04-08 | 2020-07-14 |
| Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients anlotinib - Sarcoma, Soft Tissue | Phase 2 | Unknown | Liaoning Cancer Hospital & Institute | 47 | 2019-05-20 | 2019-07-09 |
| Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment Doxorubicin, Ifosfamide, radiotherapy - Sarcoma, Soft Tissue | Phase 2 | Unknown | AC Camargo Cancer Center | 70 | 2015-03-01 | 2016-06-24 |
| Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) Adriamycin, Trofosfamide - Sarcoma, Soft Tissue | Phase 2 | Unknown | University Hospital Schleswig-Holstein | 117 | 2004-08-01 | 2013-01-08 |
Sarcoma (6)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Connective and Soft Tissue (6)
Doxorubicin (4) · Ifosfamide (2) · Radiotherapy (1) · anlotinib (1) · sintilimab (1) · trofosfamide (1)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (2) · AC Camargo Cancer Center (1) · Fudan University (1) · Liaoning Cancer Hospital & Institute (1) · University Hospital Schleswig-Holstein (1)
China (4) · Brazil (1) · Germany (1)
Ademar Lopes, Phd (1) · Joerg T. Hartmann, MD (1) · Li Shenglong, master (1) · Xiaohui Niu, Master (1)